243 related articles for article (PubMed ID: 23867918)
21. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2.
Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ
J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133
[TBL] [Abstract][Full Text] [Related]
22. Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages.
Butchi NB; Hinton DR; Stohlman SA; Kapil P; Fensterl V; Sen GC; Bergmann CC
J Virol; 2014 Jan; 88(2):1051-64. PubMed ID: 24198415
[TBL] [Abstract][Full Text] [Related]
23. The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression.
Sajid M; Ullah H; Yan K; He M; Feng J; Shereen MA; Hao R; Li Q; Guo D; Chen Y; Zhou L
Front Immunol; 2021; 12():634937. PubMed ID: 33868257
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
25. [Effect of the cytoplasmic DNA sensor DAI on replication of hepatitis B virus].
Wang Q; Li S; Huang H; Liu S; Yang Y; Yang D
Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):934-8. PubMed ID: 26739467
[TBL] [Abstract][Full Text] [Related]
26. [Zinc finger E-box-binding homeobox 2 inhibits hepatitis B virus replication and expression].
Li XP; Hu Q; He Q; Chen WX
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):824-828. PubMed ID: 27978927
[No Abstract] [Full Text] [Related]
27. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
28. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
[TBL] [Abstract][Full Text] [Related]
29. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity.
Tian H; He Z
Biomed Pharmacother; 2018 Mar; 99():774-780. PubMed ID: 29710475
[TBL] [Abstract][Full Text] [Related]
30. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells.
Rang A; Günther S; Will H
J Hepatol; 1999 Nov; 31(5):791-9. PubMed ID: 10580575
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 protein.
Zhao F; Xu G; Zhou Y; Wang L; Xie J; Ren S; Liu S; Zhu Y
J Biol Chem; 2014 Dec; 289(50):35029-41. PubMed ID: 25342750
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.
Chavalit T; Nimsamer P; Sirivassanametha K; Anuntakarun S; Saengchoowong S; Tangkijvanich P; Payungporn S
Microrna; 2020; 9(3):232-239. PubMed ID: 31686644
[TBL] [Abstract][Full Text] [Related]
35. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
36. IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA.
Fleith RC; Mears HV; Leong XY; Sanford TJ; Emmott E; Graham SC; Mansur DS; Sweeney TR
Nucleic Acids Res; 2018 Jun; 46(10):5269-5285. PubMed ID: 29554348
[TBL] [Abstract][Full Text] [Related]
37. ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of parainfluenza virus type 5 transcription and protein synthesis.
Andrejeva J; Norsted H; Habjan M; Thiel V; Goodbourn S; Randall RE
J Gen Virol; 2013 Jan; 94(Pt 1):59-68. PubMed ID: 23052390
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of hepatitis B viral replication and proteomic analysis of HepG2.2.15 cell line after knockdown of HBx.
Xie HY; Cheng J; Xing CY; Wang JJ; Su R; Wei XY; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):295-302. PubMed ID: 21669574
[TBL] [Abstract][Full Text] [Related]
39. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
40. Interferon Regulatory Factor 8 (IRF8) Impairs Induction of Interferon Induced with Tetratricopeptide Repeat Motif (IFIT) Gene Family Members.
White CL; Kessler PM; Dickerman BK; Ozato K; Sen GC
J Biol Chem; 2016 Jun; 291(26):13535-45. PubMed ID: 27137933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
